R&D invest 10~15% of Sales

Korea Pharmaceutical Manufacturers Association (KPMA) decided to concentrate on capacities of association to secure financial resources of 10~15 percent of R&D investment and further fair competition climate, so as to improve research development abilities.

KPMA clarified that as a result of holding 10 committees except foreign-affiliated firm sepecial committee simultaneously in April, th...